1. Darin N, Kadhom N, Briere JJ, Chretien D, Bebear CM, Rotig A, Munnich A, Rustin P. Mitochondrial activities in human cultured skin fibroblasts contaminated by Mycoplasma hyorhinis. BMC Biochem. 2003. 4:15.
2. Browning GF, Marenda MS, Noormohammadi AH, Markham PF. The central role of lipoproteins in the pathogenesis of mycoplasmoses. Vet Microbiol. 2011. 153:44–50.
3. Rottem S. Interaction of mycoplasmas with host cells. Physiol Rev. 2003. 83:417–432.
4. Cimolai N. Do mycoplasmas cause human cancer? Can J Microbiol. 2001. 47:691–697.
5. Choi JW, Haigh WG, Lee SP. Caveat: mycoplasma arginine deiminase masquerading as nitric oxide synthase in cell cultures. Biochim Biophys Acta. 1998. 1404:314–320.
6. Blanchard A, Bébéar CM. Shmuel R, Richard H, editors. Mycoplasmas of humans. Molecular biology and pathogenicity of mycoplasmas. 2002. New York, NY: Springer;45–71.
7. Uuskula A, Kohl PK. Genital mycoplasmas, including Mycoplasma genitalium, as sexually transmitted agents. Int J STD AIDS. 2002. 13:79–85.
8. Gilroy CB, Keat A, Taylor-Robinson D. The prevalence of Mycoplasma fermentans in patients with inflammatory arthritides. Rheumatology (Oxford). 2001. 40:1355–1358.
9. Citti C, Nouvel LX, Baranowski E. Phase and antigenic variation in mycoplasmas. Future Microbiol. 2010. 5:1073–1085.
10. Mandruzzato S. Technological platforms for microarray gene expression profiling. Adv Exp Med Biol. 2007. 593:12–18.
11. Park JY, Park YR, Park CH, Kim JH, Kim JH. Xperanto: a web-based integrated system for DNA microarray data management and analysis. Genomics Inform. 2005. 3:39–42.
12. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002. 18:Suppl 1. S96–S104.
13. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002. 30:e15.
14. Newton MA, Kendziorski CM, Richmond CS, Blattner FR, Tsui KW. On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J Comput Biol. 2001. 8:37–52.
15. Stacey GN. Cell culture contamination. Methods Mol Biol. 2011. 731:79–91.
16. Padua MB, Hansen PJ. Changes in expression of cell-cycle-related genes in PC-3 prostate cancer cells caused by ovine uterine serpin. J Cell Biochem. 2009. 107:1182–1188.
17. Shi Z, Jervis D, Nickerson PE, Chow RL. Requirement for the paired-like homeodomain transcription factor VSX1 in type 3a mouse retinal bipolar cell terminal differentiation. J Comp Neurol. 2012. 520:117–129.
18. Mizukami T, Kanai Y, Fujisawa M, Kanai-Azuma M, Kurohmaru M, Hayashi Y. Five azacytidine, a DNA methyltransferase inhibitor, specifically inhibits testicular cord formation and Sertoli cell differentiation in vitro. Mol Reprod Dev. 2008. 75:1002–1010.
19. Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet. 2011. 378:1812–1823.
20. Li Z, Zhang W, Wu M, Zhu S, Gao C, Sun L, Zhang R, Qiao N, Xue H, Hu Y, et al. Gene expression-based classification and regulatory networks of pediatric acute lymphoblastic leukemia. Blood. 2009. 114:4486–4493.
21. Bhattacharjee M, Sillanpaa MJ. A bayesian mixed regression based prediction of quantitative traits from molecular marker and gene expression data. PLoS One. 2011. 6:e26959.
22. van den Akker EB, Verbruggen B, Heijmans BT, Beekman M, Kok JN, Slagboom PE, Reinders MJ. Integrating protein-protein interaction networks with gene-gene co-expression networks improves gene signatures for classifying breast cancer metastasis. J Integr Bioinform. 2011. 8:188.